A Phase I Clinical Trial of CLL-1 CAR-T Cells for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia in Adults

被引：8

作者：

Zhang, Xiaomei ^{[1
]}

Lv, Hairong ^{[2
]}

Xiao, Xia ^{[2
]}

Bai, Xue ^{[2
]}

Liu, Pengjiang ^{[2
]}

Pu, Yedi ^{[2
]}

Meng, Juanxia ^{[2
]}

Zhu, Haibo ^{[2
]}

Wang, Zhao ^{[2
]}

Zhang, Huan ^{[2
]}

Zhang, Yu ^{[2
]}

Lv, Cuicui ^{[2
]}

Ma, Li ^{[2
]}

Yuan, Ting ^{[2
]}

Zhang, Meng ^{[2
]}

Sun, Rui ^{[1
]}

Zhao, Yifan ^{[2
]}

Cao, Xinping ^{[2
]}

Guo, Ruiting ^{[2
]}

Zhang, Yi ^{[2
]}

Guo, Shujing ^{[2
]}

Liu, Jile ^{[2
]}

Zhao, Mingfeng ^{[1
,2
]}

机构：

[1] Nankai Univ, Med Sch, Tianjin, Peoples R China

[2] Tianjin First Cent Hosp, Tianjin, Peoples R China

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-180387

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[21] Utilizing CLL-1 Positive Leukemia Stem Cells As a Marker of Early Treatment Response in Acute Myeloid Leukemia
Liu, Suhu
Lee, Christina Y.
Lan, Fengshou
Shuster, Michael
Lin, Hong
BLOOD, 2022, 140 : 9138 - 9139
[22] Phase I study of azacitidine and bortezomib in adults with relapsed or refractory acute myeloid leukemia
Walker, Alison R.
Klisovic, Rebecca B.
Garzon, Ramiro
Schaaf, Larry J.
Humphries, Kristina
Devine, Steven M.
Byrd, John C.
Grever, Michael R.
Marcucci, Guido
Blum, William
LEUKEMIA & LYMPHOMA, 2014, 55 (06) : 1304 - 1308
[23] TREATMENT OF RELAPSED AND REFRACTORY ACUTE MYELOID-LEUKEMIA IN ADULTS
LAZZARINO, M
MORRA, E
ALESSANDRINO, EP
MERANTE, S
BERNASCONI, P
BONFICHI, M
CALDERA, D
BERNASCONI, C
BONE MARROW TRANSPLANTATION, 1989, 4 : 121 - 123
[24] Phase I Trial of Lithium and Tretinoin for Treatment of Relapsed and Refractory Non-promyelocytic Acute Myeloid Leukemia
Ueda, Masumi
Stefan, Tammy
Stetson, Lindsay
Ignatz-Hoover, James J.
Tomlinson, Benjamin
Creger, Richard J.
Cooper, Brenda
Lazarus, Hillard M.
de Lima, Marcos
Wald, David N.
Caimi, Paolo F.
FRONTIERS IN ONCOLOGY, 2020, 10
[25] Tc Buster Transposon Engineered CLL-1 CAR-NK Cells Efficiently Target Acute Myeloid Leukemia
Gurney, Mark
O'Reilly, Eimear
Corcoran, Sarah
Brophy, Sarah
Hardwicke, David
Krawczyk, Janusz
Hermanson, David
Childs, Richard W.
Szegezdi, Eva
O'Dwyer, Michael E.
BLOOD, 2021, 138
[26] Phase 1 Dose Escalation Trial of Pegcrisantaspase in Combination with Venetoclax in Adults with Relapsed or Refractory Acute Myeloid Leukemia
Bollino, Dominique R.
Liu, Yuchen
Bah, Osman Mohamed
Caprinolo, Katherine
Zarrabi, Jinoos
Philip, Sunita
Mostafa, Ezzat
Lapidus, Rena G.
Singh, Zeba
Kallen, Michael
Ning, Yi
Koka, Rima
Baer, Maria R.
Niyongere, Sandrine
Duong, Vu H.
Strovel, Erin T.
Graveno, Molly
Emadi, Ashkan
BLOOD, 2022, 140 : 9044 - 9045
[27] CAR-T Cells Immunotherapies for the Treatment of Acute Myeloid Leukemia-Recent Advances
Zarychta, Julia
Kowalczyk, Adrian
Krawczyk, Milena
Lejman, Monika
Zawitkowska, Joanna
CANCERS, 2023, 15 (11)
[28] Characteristics of anti-CLL1 based CAR-T therapy for children with relapsed or refractory acute myeloid leukemia: the multi-center efficacy and safety interim analysis
Zhang, Hui
Bu, Chaoke
Peng, Zhiyong
Li, Guangchao
Zhou, Zhao
Ding, Wen
Zheng, Yongwei
He, Yingyi
Hu, Zhengbin
Pei, Kunlin
Luo, Min
Li, Chunfu
LEUKEMIA, 2022, 36 (11) : 2596 - 2604
[29] Characteristics of anti-CLL1 based CAR-T therapy for children with relapsed or refractory acute myeloid leukemia: the multi-center efficacy and safety interim analysis
Hui Zhang
Chaoke Bu
Zhiyong Peng
Guangchao Li
Zhao Zhou
Wen Ding
Yongwei Zheng
Yingyi He
Zhengbin Hu
Kunlin Pei
Min Luo
Chunfu Li
Leukemia, 2022, 36 : 2596 - 2604
[30] Naturally Selected CD7-Targeted Chimeric Antigen Receptor (CAR)-T Cell Therapy for Refractory/Relapsed Acute Myeloid Leukemia: Phase I Clinical Trial
Xian Zhang
Junfang Yang
Jingjing Li
Liyuan Qiu
Liu Hongxing, Sr.
Min Xiong
Jianqiang Li
Peihua Lu
BLOOD, 2023, 142

← 1 2 3 4 5 →